Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Asset Writedowns and Impairment: 2012-2013

Historic Asset Writedowns and Impairment for Alkermes (ALKS) over the last 1 years, with Sep 2013 value amounting to $3.3 million.

  • Alkermes' Asset Writedowns and Impairment fell 27.26% to $3.3 million in Q3 2013 from the same period last year, while for Sep 2013 it was $14.6 million, marking a year-over-year change of. This contributed to the annual value of $977,000 for FY2021, which is N/A change from last year.
  • Alkermes' Asset Writedowns and Impairment amounted to $3.3 million in Q3 2013, which was down 0.00% from $3.3 million recorded in Q2 2013.
  • Alkermes' 5-year Asset Writedowns and Impairment high stood at $4.6 million for Q3 2012, and its period low was $3.3 million during Q1 2013.
  • Over the past 2 years, Alkermes' median Asset Writedowns and Impairment value was $3.3 million (recorded in 2013), while the average stood at $3.7 million.
  • Data for Alkermes' Asset Writedowns and Impairment shows a maximum YoY decreased of 27.26% (in 2013) over the last 5 years.
  • Alkermes' Asset Writedowns and Impairment (Quarterly) stood at $4.6 million in 2012, then decreased by 27.26% to $3.3 million in 2013.
  • Its Asset Writedowns and Impairment stands at $3.3 million for Q3 2013, versus $3.3 million for Q2 2013 and $3.3 million for Q1 2013.